Equity Capital Markets

Company · CIK 1822462

Foghorn Therapeutics Inc.

CIK1822462 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressMA
ListedFHTX (Nasdaq)
First annual or quarterly report2020-12-04

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-284476
ShelfEffective
 2025-01-242026-01-124
333-262711
ShelfEffective
 2022-02-142024-08-086
333-249264
IPOFinal prospectus
 2020-10-022020-10-266

Filings

17
FiledFilingRegistrationAccession
2026-01-12424B5Shelf takedown 333-2844760001193125-26-010520
2025-03-20424B5Shelf takedown 333-2844760001628280-25-014133
2025-01-31EFFECTDeclared effective 333-2844769999999995-25-000278
2025-01-24S-3Shelf registered 333-2844760001628280-25-002469
2024-08-08424B5Shelf takedown 333-2627110001193125-24-196520
2024-05-20424B5Shelf takedown 333-2627110001193125-24-142887
2022-04-19EFFECTDeclared effective 333-2627119999999995-22-001023
2022-04-15424B5Shelf takedown 333-2627110001193125-22-106802
2022-03-14EFFECTDeclared effective 333-2627119999999995-22-000629
2022-02-14S-3Shelf registered 333-2627110001628280-22-002520
2020-10-26424B4Final prospectus 333-2492640001193125-20-276924
2020-10-23424B4Final prospectus 333-2492640001193125-20-275426
2020-10-22EFFECTDeclared effective 333-2492649999999995-20-002949
2020-10-22S-1/AAmendment 333-2492640001193125-20-274108
2020-10-19S-1/AAmendment 333-2492640001193125-20-271564
2020-10-02S-1Registration filed 333-2492640001193125-20-262469
2020-08-28DRSDraft made public 377-034730000950123-20-009426

All filings of this company · CSV